Correspondingly, its knock-down in primary cells from the Flt3-ITD/NPM1c driven model of cytogenetically normal AML retarded proliferation and/or promoted cell death or senescence to an extent that precluded further experimentation (Supplementary Fig. S6B). The gene discussed is FLT3; the disease is acute myeloid leukemia.